Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis

By Peterson Kim   McDonagh Marian   Fu Rongwei  

Psychopharmacology, Vol. 197, Iss. 1, 2008-03 ,pp. : 1-11

Springer Publishing Company

Access to resources Recommend Favorite

Cost Effectiveness of Pharmacotherapies for Attention-Deficit Hyperactivity Disorder: A Systematic Literature Review

By Wu Eric Q.  

CNS Drugs, Vol. 26, Iss. 7, 2012-07 ,pp. : 581-600

Adis International

Access to resources Recommend Favorite

Medication Costs to Private Insurers of Diversion of Medications for Attention-Deficit Hyperactivity Disorder

By Aldridge Arnie P.  

PharmacoEconomics, Vol. 29, Iss. 7, 2011-07 ,pp. : 621-635

Adis International

Access to resources Recommend Favorite

Atomoxetine: A Review of its Use in Attention-Deficit Hyperactivity Disorder in Children and Adolescents

By Garnock-Jones Karly P.   Keating Gillian M.  

Pediatric Drugs, Vol. 11, Iss. 3, 2009-05 ,pp. : 203-226

Adis International

Access to resources Recommend Favorite

Long-Term Outcomes with Medications for Attention-Deficit Hyperactivity Disorder: Current Status of Knowledge

By Huang Yu-Shu   Tsai Ming-Horng  

CNS Drugs, Vol. 25, Iss. 7, 2011-07 ,pp. : 539-554

Adis International

Access to resources Recommend Favorite